Author:
Melikian A. L.,Subortseva I. N.,Kovrigina A. M.,Kolosheynova T. I.,Abdullaev A. O.,Kuznetsova P. I.,Sudarikov A. B.,Kulikov S. M.
Publisher
LLC Obyedinennaya Redaktsiya
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference28 articles.
1. Melikyan A, Turkina A, Abdulkadyrov K, Zarickij A, Afanasev B, Shuvaev V, Lomaia E, Morozova E, Bajkov V, Golenkov A, Subortceva I, Sokolova M, Kovrigina A, Martynkevich I, Gricaev S, Sudarikov A, Suhanova G, Ivanova V,. Kaplanov K, Konstantinova T. Clinical guidelines for the diagnosis and treatment of Ph-negative myeloproliferative disorders (polycythemia vera, essential thrombocythemia, primary myelofibrosis). Gematologiya I transfuziologiya. 2014;59(4):31-56. (In Russ.)
2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
3. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C., Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B. Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis. Br J Haematol. 2005;130:174-195.
4. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia
5. Masked polycythemia Vera (mPV): Results of an international study
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献